Abstract
Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?
Original language | English |
---|---|
Pages (from-to) | 44-46 |
Number of pages | 3 |
Journal | Prescriber |
Volume | 28 |
Issue number | 4 |
DOIs | |
Publication status | Published - 30 Apr 2017 |